Ipsen Celebrates Opening of New Cambridge Headquarters with Day of Service

– Ipsen officially opens North American headquarters at One Main Street and recently renovated
R&D and Global External Innovation and Partnering facilities at 650 East Kendall Street –
– More than 115 employees join together to support nine local non-profit organizations –
Cambridge, Mass., June 20, 2019 – Ipsen Biopharmaceuticals, an affiliate of Ipsen (Euronext: IPN;
ADR: IPSEY), today celebrated the grand opening of the company’s new North American
headquarters in Cambridge, Mass. As part of the festivities, more than 115 Ipsen employees took to
the community for a Day of Service, supporting and volunteering for nine local charities and nonprofit organizations.
“At Ipsen, our dedicated employees strive every day to help improve the lives of the patients we
serve. We’re honored and thankful for their commitment to making a difference, and to having a
positive impact on the communities in which we live and work,” said Richard Paulson, CEO of Ipsen
North America. “Today is about more than marking the opening of our new Kendall Square
headquarters – it’s about teamwork and giving back, and we’re proud to be here to participate.”
Ipsen’s Day of Service was coordinated with the help of Life Science Cares, an organization
dedicated to eliminating poverty in the greater Boston area. Activities ranged from making updates
and repairs to old buildings to cooking meals for families in need, and sorting and packaging
clothing donations to prepare them for distribution. Participating organizations included:

• Boston Healthcare for the Homeless Program (BHCHP)
• Cambridge and Somerville Programs for Addiction Recovery (CASPAR)
• Cradles to Crayons Brighton
• Dimock Center Roxbury
• VA Boston Fisher House
• Breakthrough Greater Boston
• Message of Hope Foundation
• More Than Words Waltham
• Year Up Greater Boston
  
  Ipsen announced the relocation of its North American headquarters from Basking Ridge, NJ to
  Cambridge in June 2018. With the move, the company co-located its Commercial business with its
  Research & Development, Manufacturing, and Global External Innovation and Partnering teams
  already based in Kendall Square – creating a fully integrated biopharmaceutical business in the
  United States. There are currently more than 290 employees in Kendall Square, with continued
  growth planned with the addition of more than 50 roles in 2019.
  “This strategic move allows Ipsen to further capitalize on – and, importantly, invest in – the area’s
  robust biotech ecosystem to support our company’s accelerated growth, as well as leverage key
  industry partnerships and major academic prowess in the area,” added Paulson. “It also provides
  access to top talent, and an opportunity to raise our profile and visibility as an employer of choice.”
  Today’s grand opening includes celebration of Ipsen’s new 50,000-square-foot headquarters at One
  Main Street and the company’s recently renovated 46,000-square-foot facility at 650 East Kendall
  Street, home of Ipsen’s R&D and Global External Innovation and Partnering teams, as well as the
  Ipsen Innovation Center – Biolabs, a 15,000-square-foot life science co-working facility dedicated to
  supporting entrepreneurs and startup companies developing the next generation of therapeutics
  for patients. Ipsen also has a manufacturing facility located at One Kendall Square.
  Follow #WeAreIpsen on Twitter and LinkedIn to see Ipsen’s Day of Service in action and learn more
  about the company’s dedication to the greater Cambridge/Boston communities.
  ABOUT IPSEN IN NORTH AMERICA
  Ipsen (Euronext: IPN; ADR: IPSEY) is a global biopharmaceutical company focused on innovation and
  specialty care. The company develops and commercializes innovative medicines in three key
  therapeutic areas – Oncology, Neuroscience and Rare Diseases. At Ipsen, we focus our resources,
  investments and energy on discovering, developing and commercializing new therapeutic options to
  provide hope for patients whose lives are challenged by difficult-to-treat diseases. Ipsen’s North
  American operations are located in Cambridge, Massachusetts, one of the company’s three global
  hubs. Based in the heart of Kendall Square, our fully integrated biopharmaceutical business includes
  Commercial, Research & Development, Manufacturing, and Global External Innovation and
  Partnering. Combined with our Canadian headquarters in Mississauga, Ontario, and other locations,
  Ipsen employs approximately 600 people in North America. For more information please visit
  www.ipsenus.com or www.ipsen.ca. Connect with us on Twitter and LinkedIn.
  Media Contacts:
  Elliot Fox
  +1.212.257.6724
  efox@w2ogroup.com